Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Opportunities Knock On TCM Door

This article was originally published in PharmAsia News

Executive Summary

Guangzhou Xiangxue Pharmaceuticals has opened its Xiangxue traditional Chinese medicine research and development center in Cambridge, England. It will partner with the University of Cambridge and other academic institutions to investigate the science underpinning TCM efficacy, formulation standards, technical processes, and other related issues. This collaboration marks a significant step in China's focus to develop its TCM industry, earmarked as one of its strategic sectors. The current $30 billion international herbal market is growing at 10 percent to 20 percent annually and investors are eyeing the sector as a hot growth area. Many local listed enterprises are investing in TCM as an alternative strategy for transformation and expansion. (Click here for more)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC066668

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel